Impaired immunogenicity of BNT162b2 anti SARS-CoV-2 vaccine in patients treated for solid tumors

Authors :: Jérôme Barrière
O. Castelnau
Emmanuel Chamorey
E. Petit
M. Carles
V. Raimondi
S. Marco
A. Mahamat
A. Leysalle
Z. Adjtoutah
Source :: Annals of Oncology
Publication Year :: 2021
Publisher :: European Society for Medical Oncology. Published by Elsevier Ltd., 2021.

Subjects :: 2019-20 coronavirus outbreak
Oncology
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunogenicity
Medicine
In patient
Hematology
business
Virology
Letter to the Editor

Tools